Metyrapone - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for metyrapone and what is the scope of freedom to operate?
Metyrapone
is the generic ingredient in one branded drug marketed by Hra Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for metyrapone. One supplier is listed for this compound.
Summary for metyrapone
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 109 |
Clinical Trials: | 21 |
Patent Applications: | 2,413 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in metyrapone? | metyrapone excipients list |
DailyMed Link: | metyrapone at DailyMed |
Recent Clinical Trials for metyrapone
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 2 |
Maria Sklodowska-Curie National Research Institute of Oncology | Phase 2 |
Biostat Sp. z o.o. | Phase 2 |
Pharmacology for metyrapone
Drug Class | Adrenal Steroid Synthesis Inhibitor |
Mechanism of Action | Adrenal Steroid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for metyrapone
Anatomical Therapeutic Chemical (ATC) Classes for metyrapone
US Patents and Regulatory Information for metyrapone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hra Pharma | METOPIRONE | metyrapone | TABLET;ORAL | 012911-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hra Pharma | METOPIRONE | metyrapone | CAPSULE;ORAL | 012911-002 | Aug 9, 1996 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.